Daiichi Sankyo

Case Study

Integrated control of sales

Daiichi Sankyo's goal is to become a global pharmaceutical innovator by 2025, particularly in oncology. This requires not only structure, but also extensive information from the markets.

With this in mind, the global pharmaceutical company Daiichi Sankyo, in collaboration with celver AG and the SDG Group, has designed and implemented an end-to-end solution. This not only summarizes the required data from various sources in clear dashboards, but also enables data-driven decisions, especially in the functional areas of sales and marketing.

The facts at a glance

Integrated sales management
Detailed, cross-country overview of markets, i.e., customers, products, and field force performance.
Building a dashboard with all relevant KPIs in QlikSense

Advantages and benefits

  • End-to-end solution within the company for different stakeholders (from management to pharmaceutical representatives)
  • New insights through geo-analysis
  • High user acceptance
  • Fast implementation in a short project duration
Andy Maric
Andy Maric
Business Insights and Analytics Manager
Daiichi Sankyo UK
Our mission to deliver innovative medicines to patients is further strengthened by the new visual dashboards.